Skip to content
Search

Latest Stories

Coronavirus could have already infected half of UK population, says new study

An academic from the University of Oxford has led a new study to analyse the coronavirus pandemic, which indicates the vast majority of people who contract COVID-19 may suffer little or no illness.

Sunetra Gupta, a professor of theoretical epidemiology at Oxford who led the research alongside other colleagues, called on a focus on increased antibody testing to determine the levels of immunity already being built up in the UK population against the deadly virus, which has claimed 422 lives in the country.


''Even if it’s one in a hundred [who fall seriously ill] you still get to 35 per cent immunity,” said Gupta.

The new model from Oxford University suggests the virus could have been circulating in the UK since mid-January, around two weeks before the first reported case and a month before the first reported death, and may have already infected nearly half the population.

Prof. Gupta and her team of researchers caution that better information was needed on what portion of the population is vulnerable. Their study, which is based on assumptions about the most likely characteristics of the pandemic, are yet to be peer-reviewed or published in a journal but under their initial assumption-based model, half of the UK could now be immune.

“There is an inverse relationship between the proportion currently immune and the fraction of the population vulnerable to severe disease,” the study notes.

The central thrust is on greater testing as the tests being used by the NHS only show whether somebody has the disease when a sample is taken. Once the country moves to what is called serological testing, it would show whether somebody has acquired antibodies to fight it off, which would show their immunity levels as it confirmed if they have had it and recovered.

“Urgent development and assessment of such tests should be followed by rapid implementation at scale to provide real-time data. These data will be critical to the proper assessment of the effects of social distancing and other measures currently being adopted to slow down the case incidence and for informing future policy direction,” says the study.

“Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 (COVID-19) epidemic,” adds Gupta.

The UK government said on Tuesday that it had bought 3.5 million antibody tests for coronavirus, promising that frontline doctors and nurses will be able in due course to find out whether they have been infected and are safe to go back to work.

The announcement came as UK health secretary Matt Hancock addressed a video-link press briefing from Downing Street on Tuesday evening to announce that the UK would be transforming a massive conference venue in east London, the ExCel Centre, into a makeshift hospital for 4,000 patients afflicted by the pandemic.

“The NHS Nightingale hospital will comprise two wards each of 2,000 people. With the help of the military and with NHS clinicians, we will make sure that we have the capacity that we need,” he said.

According to the latest UK Department of Health figures, there are now more than 8,000 confirmed cases of coronavirus in the UK – although the actual number cases is likely to be far higher. The country is under strict social distancing and "stay at home" conditions, announced by the government earlier this week.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less